Global Heart Transplant Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Heart Transplant Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Heart Transplant Market Size Expected to Be by 2034?
In the past few years, there has been a swift increase in the size of the heart transplant market. Its growth trajectory is expected to keep increasing, rising from a worth of $11.49 billion in 2024 to an estimated $12.66 billion in 2025, thereby showing a compound annual growth rate (CAGR) of 10.2%. This impressive growth in the historical period can be ascribed to multiple factors like medical progress, heightened awareness and education, improvements in organ preservation techniques, and an enhanced healthcare infrastructure.

In the forthcoming years, the heart transplant sector is anticipated to experience robust growth. The market is projected to expand to $18.1 billion by 2029, with a cumulative annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the predicted period include government backing and finance, the international reach of transplant initiatives, the expansion of transplant center capacities, and the incorporation of telehealth and remote surveillance. The forecast period is also marked by significant trends such as technological advancements, the use of artificially created heart and support devices, as well as the application of artificial intelligence (AI) in the selection of donor organs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

What Are the Emerging Segments Within the Heart Transplant Market?
The heart transplant market covered in this report is segmented -

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types
2) By Transplant: Autograft, Allograft, Other Transplants
3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

What Long-Term Drivers Are Shaping Heart Transplant Market Trends?
The heart transplant market's growth is foreseen to be fuelled by the increasing incidence of cardiovascular diseases. These diseases, which affect the heart and blood arteries, have been a major catalyst for the demand for heart transplants, which are considered the last alternative for patients with terminal heart failure unresponsive to other treatments. Transplants can enhance life quality and longevity. For example, the British Heart Foundation reported in September 2024 that about 7.6 million people in the UK, including 4 million men and 3.6 million women, are presently dealing with heart and circulatory diseases. Forecasts suggest that these figures could see an increase of 1 million by 2030 and potentially 2 million more by 2040. Therefore, the high incidence of cardiovascular ailments is predicted to stimulate the heart transplant market. The growth of the heart transplant market is also expected to be driven by the rise in organ donation and transplantation awareness. This awareness refers to the knowledge, comprehension, and consciousness of individuals and communities about organ donation and transplantation's processes, importance, and effects on healthcare. This heightened awareness greatly impacts the heart transplant field by enlarging the donor pool, reducing wait times for recipients, and improving patient outcomes. For instance, the United Network for Organ Sharing reported in January 2023 that a new annual record of 42,887 organ transplants, a 3.7% increase from 2021, was achieved in the US in 2022. Among these procedures, established awareness helped perform 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants. Therefore, an increase in organ donation and transplantation awareness is projected to stimulate the heart transplant market.

Who Are the Top Competitors in Key Heart Transplant Market Segments?
Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

What Are the Major Trends Shaping the Heart Transplant Market?
Leading enterprises in the heart transplant market are constantly striving to develop novel solutions, such as heart preservation technology, to enhance patient results and the success rate of transplants. This technology significantly prolongs the time a heart can be preserved outside the body compared to conventional ice storage methods, leading to improved transplant outcomes and fewer post-transplant complications. In May 2023, for example, the U.S. Food and Drug Administration (FDA) approved the Investigational Device Exemption (IDE) application for Xvivo Perfusion AB, a medical technology firm based in Sweden, for its heart preservation technology. This allowed the company to begin the "PRESERVE Clinical Trial," a forward-looking, multicenter, single-arm, open-label study, aimed at evaluating hearts that have been transplanted following non-ischemic heart preservation from extended donors, with a particular focus on Donation after Circulatory Death (DCD) hearts. The distinguishing aspect of XVIVO's heart preservation technology is its non-ischemic hypothermic perfusion system, which employs cold, oxygenated perfusion to maintain donor hearts during transportation.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Which Regions Are Becoming Hubs for Heart Transplant Market Innovation?
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Heart Transplant Market?
2. What is the CAGR expected in the Heart Transplant Market?
3. What Are the Key Innovations Transforming the Heart Transplant Industry?
4. Which Region Is Leading the Heart Transplant Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.